Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma.
Saved in:
| Title: | Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma. |
|---|---|
| Authors: | Vartanian A; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Agnihotri S; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Wilson MR; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Burrell KE; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Tonge PD; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Alamsahebpour A; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Jalali S; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Taccone MS; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Mansouri S; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Golbourn B; Arthur and Sonia Labatt Brain Tumour Research Centre, SickKids Hospital, Toronto, Canada., Aldape KD; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Zadeh G; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada.; Arthur and Sonia Labatt Brain Tumour Research Centre, SickKids Hospital, Toronto, Canada.; University Health Network, Toronto Western Hospital, Toronto, Canada. |
| Source: | Oncotarget [Oncotarget] 2016 Oct 25; Vol. 7 (43), pp. 69518-69535. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
